Lilly Sees Profit Lifted by Newer Drugs
615212
Eli Lilly and Co. LLY.N on Thursday  said it expects earnings in 2005 to rise to between $3.05 and  $3.15 per share before special items as growing sales of newer  medicines more than offset disappointing sales of its  top-selling schizophrenia drug.
402815
NEW YORK -- Pharmaceutical company Eli Lilly and Co. on Thursday issued 2007 earnings estimates that are below Wall Street's current expectations.
515541
INDIANAPOLIS, July 24  â Eli Lilly, with help from its core medicines Zyprexa and Cymbalta, beat Wall Streetâs second-quarter expectations Tuesday, although profits fell 19 percent at the pharmaceutical company because of acquisition costs.
16405
Eli Lilly and Co.  on Tuesday posted better-than-expected second-quarter earnings helped by surging sales of its prescription drugs, including depression treatment Cymbalta, and the company raised its 2007 profit forecast.
245874
Eli Lilly and Co.  said on Thursday it is on track to meet its 2006 growth forecast of 8 percent to 12 percent, but projected slower profit growth in 2007 though its revenues will grow at a faster pace next year.
161514
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on higher-than-expected sales of its medicines, including strong demand for its newer treatments for depression, diabetes and cancer.
356134
Merck & Co  on Monday said its  third-quarter profit rose sharply, helped by sales of its  vaccines and cholesterol drugs, and raised its 2007 profit  forecast in view of strong current trends.
387898
Pfizer Inc, Novartis AG and Wyeth all  saw quarterly earnings hit by charges on Thursday, while Eli  Lilly and Co exceeded Wall Street expectations as third-quarter  sales of several of its drugs outpaced analysts' estimates.
725823
NEW YORK/GROTON, Connecticut  - Pfizer Inc.  raised its 2006 profit forecast on Thursday and said its roster of experimental drugs in late-stage testing could triple by 2009, sending its shares higher.
53410
Walgreen Co. (WAG.N: Quote, Profile, Research) , the top US drugstore chain, on Monday said quarterly profit rose 18.1 percent on strong sales of prescription drugs, digital photo
696929
Eli Lilly & Company said it expected higher costs to keep next yearÂs profit gains below its expected 2006 growth of 8 percent to 12 percent.
712690
Eli Lilly &amp; Co. said Thursday it expects 2005 earnings, excluding the impact of expensing stock options, to be in line with analysts&#39; views.
736352
Pfizer Inc.  on Wednesday said third-quarter earnings rose on higher sales of cholesterol and arthritis drugs, but the company cautioned that 2005 results will likely be hurt by generic competition for four other popular medicines.
308820
Abbott Laboratories Inc.  on Tuesday said its fourth-quarter profit rose 3.2 percent on higher sales of its prescription drugs, including its popular new treatment for rheumatoid arthritis, Humira.
448727
Pharmaceutical group Sanofi-Synthelabo said it had increased net profit in the first half of the year by 20.6 percent from the same period last year to 1.138 billion euros (1.38 billion dollars).
371394
Stock futures rose on Monday as deal news and stronger-than-expected profits from drug maker Merck & Co.  and others eased anxiety about earnings, which led to Friday's sell-off.
298049
The pharmaceutical company reported a 5 percent increase in fourth-quarter earnings but said growth would slow this year as generic competition picked up.